AI assistant
STANDARD BIOTOOLS INC. — Director's Dealing 2018
May 24, 2018
32853_dirs_2018-05-24_8b7277d9-8ac9-4484-8148-faa596a22017.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: FLUIDIGM CORP (FLDM)
CIK: 0001162194
Period of Report: 2018-05-14
Reporting Person: Kreger Bradley Allen (SVP, Global Operations)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Restricted Stock Units | $ | Common Stock (50000.0) | Direct | ||
| Employee Stock Option (Right to Buy) | $5.46 | 2028-05-08 | Common Stock (100000.0) | Direct |
Footnotes
F1: 12/48th of the total number of shares underlying the Restricted Stock Units granted will vest on May 20, 2019, and 3/48th of the total number of shares underlying the Restricted Stock Units granted will vest every three months thereafter until fully vested, subject to the Reporting Person's continued status as a Service Provider (as defined in the Company's 2017 Inducement Award Plan) through the applicable vest date.
F2: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit.
F3: 25% of the total number of shares subject to the Option will vest on April 2, 2019 and 1/48th of the total shares subject to the Option will vest and become exercisable each month thereafter over the succeeding 36 months, such that the Option will be fully vested on April 2, 2022, subject to the Reporting Person's continued status as a Service Provider (as defined in the Company's 2017 Inducement Award Plan) through each applicable vest date.